Glucurolactone
CAS 32449-92-6
Glucurolactone (CAS 32449-92-6) is a pharmaceutical compound with 0 bioactivity targets and 3 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Glucurolactone used for in pharmaceutical contexts?
Glucurolactone (CAS 32449-92-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Glucurolactone?
Glucurolactone has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Alanine aminotransferase increased, Aspartate aminotransferase increased, Hepatic function abnormal. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Glucurolactone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Glucuronolactone with EU status "permitted".
What clinical phase is Glucurolactone in?
No phase 1-4 clinical development badge is rendered for Glucurolactone because the matched compound identifier rows do not contain a max-phase value.